2,099 results match your criteria: "Houston Methodist Hospital - DeBakey Heart & Vascular Center[Affiliation]"

Background: The impact of COVID-19 reaches the overall well-being of women surgeons. We aimed to describe the impact of transitioning to a new challenging environment.

Methods: A survey of 60 quantitative questions using a Likert-like scale was distributed electronically via email across 1200 members of the Association of Women Surgeons in 2021.

View Article and Find Full Text PDF

Transcatheter aortic valve replacement (TAVR) is the treatment of choice for patients with severe aortic stenosis across the spectrum of surgical risk. About one-third of 30-day readmissions following TAVR are related to heart failure (HF). Hence, we aim to develop an easy-to-use clinical predictive model to identify patients at risk for HF readmission.

View Article and Find Full Text PDF

Background: The optimal treatment strategy of patients with pulmonary embolism (PE) (especially those with intermediate risk) continues to evolve and remains controversial.

Objectives: This study sought to compare the efficacy and safety of anticoagulation (AC) alone, catheter-directed thrombolysis (CDT), and systemic thrombolysis (ST) in patients with acute PE.

Methods: PubMed and EMBASE were searched for randomized controlled trials or observational studies which compared outcomes of AC alone, CDT, and ST in acute PE.

View Article and Find Full Text PDF

Intracoronary imaging has become an important tool in the treatment of complex lesions with percutaneous coronary intervention (PCI). This retrospective cohort study identified 1,118,475 patients with PCI from the Nationwide Readmissions Database from 2017 to 2019. Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) were identified with appropriate International Classification of Diseases, Tenth Revision codes.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to differentiate between obstructive coronary artery disease (CAD) and conditions like microvascular dysfunction using a new measurement called integrated myocardial flow reserve (iMFR).
  • Researchers analyzed data from over 1,200 patients undergoing myocardial perfusion imaging and validated their findings against invasive coronary angiography.
  • Results indicate that iMFR improves diagnostic accuracy for obstructive CAD, particularly in cases of focally impaired perfusion, while diffusely impaired perfusion may suggest a lower risk of obstructive CAD.
View Article and Find Full Text PDF

Endovascular retrieval of fractured inferior vena cava (IVC) filters after the manufacturer recommended indwelling time can be challenging and require advanced retrieval techniques. We describe an endovascular retrieval technique of a fractured Optease IVC filter in a 57-year-old woman using endobronchial forceps and intraoperative cone-beam computed tomography guidance. Following incomplete filter retrieval, the location and orientation of fractured strut was confirmed by cone-beam computed tomography venography.

View Article and Find Full Text PDF

Background: Non-obstructing small coronary plaques may not be well recognized by expert readers during coronary computed tomography angiography (CCTA) evaluation. Recent developments in atherosclerosis imaging quantitative computed tomography (AI-QCT) enabled by machine learning allow for whole-heart coronary phenotyping of atherosclerosis, but its diagnostic role for detection of small plaques on CCTA is unknown.

Methods: We performed AI-QCT in patients who underwent serial CCTA in the multinational PARADIGM study.

View Article and Find Full Text PDF

A 59-year-old male patient with history of rheumatic heart disease with 3 previous surgical aortic valve replacements with the last one being homograft followed by transcatheter aortic valve implantation in failed homograft presented with severe aortic regurgitation and cardiogenic shock requiring urgent TAV-in-TAV-in homograft. ().

View Article and Find Full Text PDF

Background: Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation of atrial fibrillation (AF); however, the results are suboptimal for persistent AF. The left atrial posterior wall (LAPW) is thought to be a major additional area in initiation and perpetuation of persistent AF. Therefore, adjunctive ablation of the posterior wall may reduce AF recurrence in patients with persistent AF.

View Article and Find Full Text PDF

Background: The contemporary burden and characteristics of coronary atherosclerosis, assessed using coronary computed tomography angiography (CCTA), is unknown among asymptomatic adults with diabetes and prediabetes in the United States. The pooled cohort equations and coronary artery calcium (CAC) score stratify atherosclerotic cardiovascular disease risk, but their association with CCTA findings across glycemic categories is not well established.

Methods: Asymptomatic adults without atherosclerotic cardiovascular disease enrolled in the Miami Heart Study were included.

View Article and Find Full Text PDF

Effects of renin-angiotensin-aldosterone-system inhibitors on coronary atherosclerotic plaques: The PARADIGM registry.

Atherosclerosis

October 2023

Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, South Korea; Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.

Background And Aims: Inhibition of Renin-Angiotensin-Aldosterone-System (RAAS) has been hypothesized to improve endothelial function and reduce plaque inflammation, however, their impact on the progression of coronary atherosclerosis is unclear. We aim to study the effects of RAAS inhibitor on plaque progression and composition assessed by serial coronary CT angiography (CCTA).

Methods: We performed a prospective, multinational study consisting of a registry of patients without history of CAD, who underwent serial CCTAs.

View Article and Find Full Text PDF

With the growing prevalence and mortality of peripheral arterial disease, preoperative assessment, risk stratification, and determining the correct indication for endovascular and open surgical procedures are essential for therapeutic decision-making. The effectiveness of interventional procedures is significantly influenced by the plaque composition and calcification pattern. Therefore, the identification of patients for whom endovascular treatment is the most appropriate therapeutic solution often remains a challenge.

View Article and Find Full Text PDF

Background The clinical significance of mitral annular calcification (MAC) in patients undergoing mitral transcatheter edge-to-edge repair is not well understood. There is limited evidence regarding the feasibility, durability of repair, and the prognostic value of MAC in this population. We sought to examine the prognostic value of MAC, its severity, and its impact on procedural success and durability of mitral transcatheter edge-to-edge repair.

View Article and Find Full Text PDF

Progression of non-obstructive coronary plaque: a practical CCTA-based risk score from the PARADIGM registry.

Eur Radiol

April 2024

Yonsei‑Cedars‑Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.

Objectives: No clear recommendations are endorsed by the different scientific societies on the clinical use of repeat coronary computed tomography angiography (CCTA) in patients with non-obstructive coronary artery disease (CAD). This study aimed to develop and validate a practical CCTA risk score to predict medium-term disease progression in patients at a low-to-intermediate probability of CAD.

Methods: Patients were part of the Progression of AtheRosclerotic PlAque Determined by Computed Tomographic Angiography Imaging (PARADIGM) registry.

View Article and Find Full Text PDF

Background And Aims: Positron Emission Tomography (PET)-derived myocardial flow reserve (MFR) has been shown to have a role in the diagnosis and prognosis of patients with coronary artery disease (CAD). We performed a systematic review and meta-analysis to summarize the body of literature and synthesize the evidence on the prognostic role of PET-derived MFR in patients with known or suspected CAD.

Methods: A comprehensive literature search of the Medline database from its inception to August 2023, in humans, in any language, was conducted for clinical studies examining the prognostic value of PET imaging in patients of any age, sex, and CAD status.

View Article and Find Full Text PDF

Background And Aims: Coronary computed tomography angiography (CCTA) can guide downstream preventive treatment and improve patient prognosis, but its use in relation to education level remains unexplored.

Methods: This nationwide register-based cohort study assessed all residents in Denmark between 2008 and 2018 without coronary artery disease (CAD) and 50-80 years of age (n = 1 469 724). Residents were divided according to four levels of education: low, lower-mid, higher-mid, and high.

View Article and Find Full Text PDF
Article Synopsis
  • - McLeod's syndrome (MLS) is an X-linked genetic disorder linked to the XK gene that results in neurological issues and heart problems, specifically cardiomyopathy.
  • - The case discussed involves a 44-year-old White male experiencing a severe heart failure flare-up due to MLS.
  • - Treatment included following standard medical guidelines and using an implantable cardioverter defibrillator, leading to improvement in his heart's ejection fraction.
View Article and Find Full Text PDF

Mapping Geographic Proximity to Cardiologists Across the United States.

Circ Cardiovasc Qual Outcomes

October 2023

Division of Cardiovascular Medicine, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, OH (I.M., Z.C., M.H.E.M., P.R.V.O.S., S.R., S.G.A.-K.).

View Article and Find Full Text PDF

Think Outside the Heart: An Unusual Cause of Large Hemopericardium.

Methodist Debakey Cardiovasc J

September 2023

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US.

Pericardial effusions secondary to tumors are commonly metastatic, originating primarily from the lung, breast, and lymphomas. Pericardial tamponade is a rare oncological emergency warranting early identification and treatment. We describe a 66-year-old male found to have a large bloody pericardial effusion causing tamponade physiology, and multimodality imaging was consistent with intrapericardial malignancy with no identifiable primary source.

View Article and Find Full Text PDF

Heart failure remains a significant cause of mortality in the United States and around the world. While organ transplantation is acknowledged as the gold standard treatment for end stage heart failure, supply is limited, and many patients are treated with left ventricular assist devices (LVADs). LVADs extend and improve patients' lives, but they are not without their own complications, particularly the hemocompatibility related adverse events (HRAE) including stroke, bleeding and pump thrombosis.

View Article and Find Full Text PDF

Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study.

Circulation

September 2023

The Davis Heart and Lung Research Institute (G.J.H., E.J., J.C., D.D.K., H.N., R.E.H.), Department of Internal Medicine, The Ohio State University, Columbus.

Article Synopsis
  • The study investigates the genetic factors associated with advanced dilated cardiomyopathy (DCM), particularly focusing on rare genetic variants related to patients requiring devices like left ventricular assist devices (LVAD) or heart transplants (HT).
  • Researchers analyzed data from a diverse group of 1,198 patients enrolled in a precision medicine study, classifying the severity of DCM based on treatment type and assessing genetic variants in 36 related genes.
  • Findings revealed that 26.2% of patients with advanced DCM (LVAD/HT) had pathogenic genetic variants, significantly more than those with only an implantable cardioverter defibrillator (15.9%) or neither treatment (15.0%), indicating a strong genetic link to
View Article and Find Full Text PDF
Article Synopsis
  • The OCEAN(a)-Outcomes trial is investigating if lowering Lp(a) levels can reduce cardiovascular events in patients who have had a myocardial infarction or PCI and have high Lp(a) levels (≥200 nmol/L).
  • This study analyzed data from 3,142 patients aged 18-85 with previous MI or PCI, measuring Lp(a) between 2000 and 2019, finding that 12.3% had elevated Lp(a).
  • Results showed a significantly higher rate of major cardiovascular events in patients with elevated Lp(a) compared to those without, suggesting that high Lp(a) is linked to increased cardiovascular risk.
View Article and Find Full Text PDF